FOXC2 and breast carcinoma: Weinberg and colleagues found that expression of FOXC2 was induced in cells undergoing epithelial-mesenchymal transition (EMT), and FOXC2 was correlated with the highly aggressive basal-like subtype of human breast cancers [10].